Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoechst Pakistan's gross profit for the
three
months ended in Mar. 2026 was ₨2,968 Mil. Hoechst Pakistan's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was ₨11,595 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Hoechst Pakistan's gross profit for the
three
months ended in Mar. 2026 was ₨2,968 Mil. Hoechst Pakistan's Revenue for the
three
months ended in Mar. 2026 was ₨7,699 Mil. Therefore, Hoechst Pakistan's Gross Margin % for the quarter that ended in Mar. 2026 was 38.54%.
Hoechst Pakistan had a gross margin of 38.54% for the quarter that ended in Mar. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of Hoechst Pakistan was 37.31%. The lowest was 25.69%. And the median was 28.71%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Hoechst Pakistan had a gross margin of 38.54% for the quarter that ended in Mar. 2026 => Competition eroding margins
Hoechst Pakistan Gross Profit Related Terms
Hoechst Pakistan Gross Profit Historical Data
* Premium members only.
The historical data trend for Hoechst Pakistan's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAR:HPL vs LLY, JNJ, ABBV: Gross Profit Comparison
For the Drug Manufacturers - General subindustry, Hoechst Pakistan's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoechst Pakistan Gross Profit vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's Gross Profit distribution charts can be found below:
* The bar in red indicates where Hoechst Pakistan's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨11,595 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Hoechst Pakistan (KAR:HPL) has a Gross Profit of ₨11,595 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Hoechst Pakistan and its competitors.
Is Hoechst Pakistan's Gross Profit too high?
Hoechst Pakistan's current Gross Profit is ₨11,595 Mil. Overall, Hoechst Pakistan has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoechst Pakistan's Gross Profit compare to LLY and JNJ?
Hoechst Pakistan's Gross Profit of ₨11,595 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Hoechst Pakistan and its competitors. Hoechst Pakistan's current Gross Profit is ₨11,595 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoechst Pakistan stock overvalued right now?
Based on GuruFocus' analysis, Hoechst Pakistan (KAR:HPL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨3,356.40, compared to a current price of ₨4,045.49 — trading 20.5% above its estimated fair value. The current Gross Profit is ₨11,595 Mil. Hoechst Pakistan's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Hoechst Pakistan (KAR:HPL), the current Gross Profit is ₨11,595 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoechst Pakistan (KAR:HPL) Overvalued in 2026?
Based on GuruFocus' analysis, Hoechst Pakistan stock appears to be overvalued.
The current stock price of ₨4,045.49 is trading 20.5% above its estimated GF Value™ of ₨3,356.40.
GuruFocus considers Hoechst Pakistan to be Modestly Overvalued.
Key valuation signals for KAR:HPL:
Gross Profit: ₨11,595 Mil
GF Value™: ₨3,356.40 vs. price of ₨4,045.49 (20.5% above fair value)
No single metric tells the full story. See the KAR:HPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoechst Pakistan Ltd is a healthcare company of Pakistan, focused on patient needs and engaged in the manufacturing, promotion, and sale of pharmaceutical and vaccines. The company engages in the manufacturing, selling and trading of pharmaceutical and related products.
88GF Score
Get the complete analysis for KAR:HPL
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:HPL has been successfully added to your 
